Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
With the rapid expansion of the cell and gene therapy market, innovators will require reliable supply chain solutions to enable the safe and efficient transportation of products to patients in need.
The following article highlights several industry challenges and key consideration as clients prepare for commercialization of advanced therapy products, including: